Background: Ruptured abdominal aortic aneurysm is one of the most difficult clinical problems in surgical practice, with extraordinarily high morbidity and mortality.
Edwards Lifesciences Corporation announced that it has received CE Mark for the Edwards Pascal transcatheter valve repair system for the treatment of European patients with tricuspid regurgitation.
GlaxoSmithKline has announced the European Commission has granted conditional marketing authorisation for Jemperli(dostarlimab), a programmed death receptor-1 (PD-1)-blocking antibody, for use in women with mismatch repair-deficient (dMMR)/microsatellite instability-high (MSI-H) recurrent or advanced endometrial cancer who have progressed on or following prior treatment with a platinum containing regimen.
Tissue Regeneration Systems has received 510(K) approval from the FDA for its Cranial Bone Void Filler product, indicated for use...
Objective: To review current knowledge on the prevalence and clinical significance of aberrations in DNA repair genes in PC, particularly in metastatic disease.
Actelion Pharmaceuticals announced an interim analysis from the Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension (REPAIR) study of Opsumit (macitentan)...
Purpose of Review: Genomic studies of localized and metastatic prostate cancer have identified a high prevalence of clinically actionable alterations including mutations in DNA repair genes.
Regentis Biomaterials has received European CE Mark approval for its GelrinC biodegradable implant, for Cartilage Repair. GelrinC is suitable for...
Abbott announced it received approval from the FDA for a next-generation version of its leading MitraClip heart valve repair device...
Merck has announced results from the first study evaluating the correlation of benefit with an immunotherapy based on DNA mismatch...